NCT05618249 (Etaliepre-IPP) is a clinical trial in Peptic Ulcer Disease, sponsored by University Hospital, Strasbourg, France.

Who is sponsoring NCT05618249?

NCT05618249 is sponsored by University Hospital, Strasbourg, France.

What condition does NCT05618249 study?

NCT05618249 studies Peptic Ulcer Disease.

Is NCT05618249 still recruiting?

NCT05618249 is currently completed. Last updated 15 December 2023.

Last reviewed 2023-12-15 · How we verify

NCT05618249: Etaliepre-IPP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age

Completed Last updated 15 December 2023

What this trial tests

trial in Peptic Ulcer Disease in 100 participants. Completed in 30 August 2020.

Timeline

1 January 2020

Primary endpoint
30 June 2020

30 August 2020

Quick facts

Lead sponsor	University Hospital, Strasbourg, France
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2020
Primary completion	30 June 2020
Estimated completion	30 August 2020
Sites	1 location across France

Conditions studied

Peptic Ulcer Disease — all drugs for Peptic Ulcer Disease →

Sponsor

University Hospital, Strasbourg, France

Who can join

75 and older, any sex, with Peptic Ulcer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study would have as a starting point the results of a request carried out by the Medical Service Grand Est of the Health Insurance aiming to evaluate the number of boxes of PPI reimbursed in town pharmacy, in patients over 75 years old in the Grand Est of France from 01/01/2018 to 31/12/2018. It aims to highlight and quantify a possible inappropriate use of PPIs in private practice.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Strasbourg, France trials

Trials by the same sponsor.

NCT07418554 — Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Pla · Phase 3 · not yet recruiting
NCT07108582 — Reducing Chronic Pain After Lung Surgery: A Trial of Limiting NSAIDs During Recovery · Phase 3 · not yet recruiting
NCT07302646 — Optimizing Reduced-Flow, Low-Volume Contrast Protocols for Cerebral Angiography in Unruptured Aneurysms · NA · not yet recruiting
NCT07273968 — Clinical Study Evaluating the Effect of Virtual Reality on Reducing Patients' Anxiety During Wisdom Teeth Extraction · NA · not yet recruiting
NCT07214103 — Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulop · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05618249 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Strasbourg, France
Last refreshed: 15 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05618249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing